Compounds > crizotinib

crizotinib and Lymphoma--T-Cell--Peripheral

crizotinib has been researched along with Lymphoma--T-Cell--Peripheral* in 1 studies

Other Studies

1 other study(ies) available for crizotinib and Lymphoma--T-Cell--Peripheral

ArticleYear
Combination of crizotinib and chemotherapy in patients with relapsed or refractory anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma (ALCL).
    Leukemia & lymphoma, 2021, Volume: 62, Issue:3

    Topics: Anaplastic Lymphoma Kinase; Crizotinib; Humans; Lung Neoplasms; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell, Peripheral; Progression-Free Survival; Protein Kinase Inhibitors

2021